Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,417 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

NCT01435343

Conditions
Acute Myeloblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Hospital Universitari Germans Trials i Pujol Badalona, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau. Barcelona, Spain
  • Hospital Duran i Reynals - ICO L'Hospitalet Barcelona, Spain
View Trial Details
Completed

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy

NCT00816049

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Department of Pediatrics, Rigshospitalet Copenhagen, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • University Hospital Reykjavik, Iceland
  • Trondheim University Hospital Trondheim, Norway
View Trial Details
Completed

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

NCT00819351

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Department of Pediatrics, Rigshospitalet Copenhagen, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • University Hospital Reykjavik, Iceland Reykjavik, Iceland
  • Trondheim University Hospital Trondheim, Norway
View Trial Details
Completed

All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00151255

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Department of Hematology/Oncology, University Hospital of Innsbruck Innsbruck, Austria
  • Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern Linz, Austria
  • Medical Department III, St. Johann Hospital Salzburg, Austria
  • Center of hematology and oncology, Hanusch Hospital Vienna, Austria
View all 29 locations
View Trial Details
Completed

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01868893

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • University of California San Diego La Jolla, California, United States
  • Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States
View all 19 locations
View Trial Details
Completed

A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)

NCT01414205

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Univ of Alabama at Birmingham; UAB Comprehensive Cancer Ctr Birmingham, Alabama, United States
  • Arizona Oncology Tucson, Arizona, United States
  • Arizona Clinical Research Ctr Tucson, Arizona, United States
  • University of California; Moores Cancer Center La Jolla, California, United States
View all 31 locations
View Trial Details
Completed

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

NCT01363297

Conditions
Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Unversity Cancer Clinical Trials Office Palo Alto, California, United States
  • Stanford Unversity Hospital and Clinics, CTRU Palo Alto, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 15 locations
View Trial Details

Related conditions